Successful Treatment of Severe Psoriasis in an Adolescent with Ustekinumab

By  

PEDIATRIC DERMATOLOGY, Vol. 32, Iss. 3, 2015-05 ,pp. : 377-380

John Wiley & Sons Inc

Access to resources Recommend Favorite

Onset of psoriatic arthritis during ustekinumab treatment for psoriasis: a case series of seven patients

By  

BRITISH JOURNAL OF DERMATOLOGY, Vol. 173, Iss. 1, 2015-07 ,pp. : 272-274

John Wiley & Sons Inc

Access to resources Recommend Favorite

Monoclonal gammopathy of undetermined significance (MGUS) in patients with psoriasis may be associated with long‐term treatment with efalizumab, but not with anti‐TNF‐α treatments or ustekinumab

By  

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY & VENEREOLOGY, Vol. 29, Iss. 3, 2015-03 ,pp. : 609-611

John Wiley & Sons Inc

Access to resources Recommend Favorite

Long persistence of tumour necrosis factor‐α antagonist‐induced autoantibodies under subsequent treatment with ustekinumab but no adverse effects: a case study of 14 patients with psoriasis

By  

BRITISH JOURNAL OF DERMATOLOGY, Vol. 178, Iss. 1, 2018-01 ,pp. : e9-e10

John Wiley & Sons Inc

Access to resources Recommend Favorite

Paradoxical ulcerative colitis during adalimumab treatment of psoriasis resolved by switch to ustekinumab

By  

BRITISH JOURNAL OF DERMATOLOGY, Vol. 178, Iss. 2, 2018-02 ,pp. : 551-555

John Wiley & Sons Inc

Access to resources Recommend Favorite